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R. Kaiser, A. Bolte)
The prenatal fetal diagnosis of heart rate anomalies
is made by fetal electrocardiography [l, 2]. Ar-
rhythmias äs well äs heart rate anomalies have
been described; incidence and clinical significance
have been reported elsewhere [l, 2, 11]. In this
study of three individual cases the diagnosis and
therapy of fetal heart rate anomalies will be dis-
cussed. In one of the cases a paroxysmal fetal
tachycardia was treated successfully. One of the
drugs used was Verapamil and its use offered the
opportunity to investigate its placental transfer
which had previously been unknown in the human.
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l Cases
Case 1: M.W., 21 year-old II Para after Cesarean
Section three years before. She was admitted one
day before her due date because a fetal brady-
cardia was noted on auscultation. The cardio-
gram demonstrated a persistent fetal bradycardia
of 70 to 80 beats/minute. The fetal ECG (Fig. 1)
documented a bradycardia with a rate of 72 to 78
beats/minute. An AV block was suspected. On the




Fig. 1. Above: prenatal fetal ECG in the 40th week of gestation: fetal bradycardia with complete AVblock. Rate 72-80
per minute, amplitude 68.0 V. Below: neonatal ECG postpartum with continuous AV block.
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performed. A healthy appearing boy with a birth
weight of 3400 gram, length 51 cm, APGAR score
8 at one minute was born. An electrocardiogram
obtained immediately after birth (fig. l, below)
confirmed the complete AV block with complete
dissociation of atrial and ventricular activity. The
AV block converted spontaneously into a normal
conduction after one week; no cause of the
rhythm disturbance was found.
Case 2: A.S., 27 year-old primigravida four days
before her EDC. A fetal ECG demonstrated extra-
systoles (Fig. 2) with a rate of 132 to 156 beats/
minute. Because of the fetal maturity and a favor-
able cervix (BiSHOP score 5) the birth was induced
with amniotomy and oxytocin infusion (8 mE/
min). Fetal heart rate was recorded continuously
from a scalp electrode and labor was recorded from
intra-amniotic pressure recordings (Hewlett-
Packard cardiotocograph 8030A). During delivery
irregularly occurring exträsystoles were seen on
the osciüoscope, simultaneously the recorder









Fig. 3. Cardiographic recording of fetal exträsystoles.
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Fig. 4. Prenatal fetal EGG in the 33rd week of gestation. Fetal paroxysmal tachycardia. Rate 264-282 per minute,
amplitude 32.1 .
amplitude without pen-lift (Fig. 3). These should
be interpreted äs fetal arrhythmias and not äs arti-
facts which have other characteristics. After the
birth of a healthy appearing girl (3700 grams,
59 cm, APGAR score 9) the immediately recorded
neonatal ECG showed occasional ventricular extra-
systoles during 30 minutes. Another ECG recorded
oh the following day demonstrated normal sinus
rhythm äs did follow-up recordings. A cause for
the rhythm disturbance was not found.
Case 3: N.H., 28 year-old II Para was admitted in
the 33rd week of gestation because an auscultation
had demonstrated an extreme fetal tachycardia of
240 to 280 beats/minute. Previously, the course of
pregnancy had been unremarkable and except for
an iron preparation no drugs had been taken. The
maternal heart rate was normal. The fetal tachy-
cardia persisted unchanged for 10 day s. Because of
the tachycardia a cardiographic recording did not
succeed. The fetal ECG (Fig. 4) documented a fetal
tachy-arrhythmia with a rate between 264 and 282
beats/minute. This rate was documented sono-
graphically with a time-motion recording (Fig. 6).
From the ultrasonogram ascites was suspected äs
indication for early cardiac failure (Fig. 5); there-
fore the m other was treated with 0-acetyldigoxin
and Verapamil. 0-acetyldigoxin following loading
was maintained with a dose of 0.4 mg per day and
the dose of Verapamil was 80 mg three times
daily. During the four days after onset of treat-
ment the tachy-arrhythmia slowed transiently to
180—196 per minute. Five days after complete
digitalization and administration of Veramapil the
fetal heart rate was normal with a rate of 138—150
per minute. This rate persisted while therapy was
continued until delivery in the 39th week of preg-
nancy. Delivery was induced three days before the
due date. The infant (3200 grams, 49 cm, APGAR
score 9) had a sinus rhythm with the rate of
160—170 per minute during the first days of life.
There were no signs of cardiae hypertrophy or
disturbances in repolarisation. The AV conduc-
tion time was normal. Since in contrast to digoxin
the Veramapil had not been shown to pass through
the placenta in the human we investigated the
placental passage of this substance during treat-
ment.
Fig. 5. Early fetal ascites in an ultrasonogram during the
33rd week of gestation. The tiansverse section at the level Fig. 6. Fetal cardiac activity (arrow) with^ the Jime-
of the fetal kidneys. The arrow indicates a curvilinear " ~" -·—-*- ™ ~ i·—· *-i i«
layer of ascites.
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2 Pharmacokinetics of Verapamil
2.1 Materials and methods
Six pregnant women whose deliveries were in-
duced at term with a mature fetus and favorable
cervix received during the first phase of labor
80 mg of Verapamil orally when the cervical dila-
tion was 3—4 cm. Infants were born between 49
and 564 minutes after the drug administration.
Blood was obtained immediately after birth from
the antecubital vein and the umbilical vein. Plasma
samples were analyzed for concentration of Vera-
pamil in a gas Chromatograph with the nitrogen
specific flame ionization detector [4]. The lower
limit of sensitivity is 4 ng/ml Verapamil.
,2.2 Results (Tab. I)
In the maternal plasma Verapamil was found up to
173 minutes after an oral dose of 80 mg. After
three hours the Verapamil levels were below the
detectable levels. Verapamil was found at levels of
15.4 and 24.5 ng/ml after 49 and 109 minutes. No
detectable amounts of the drug were found in
samples obtained later.
3 Discussion
The diagnosis of fetal heart rate anomalies is made
from the fetal ECG. Because of physiologically
low voltage it may in exceptional cases be difficult
between the 29th and 35th week of gestation [l,
2]. Changes of cardiac rhythm such äs a complete
AV block or paroxsymal tachycardia may be re-
corded with the generally available cardiotoco-
graphs if the rates are not outside the ränge of
50—210 beats per minute. However, cardiotoco-
graph will allow the rec^gnition of rhythm ano-
malies only in cases in which the fetal Signals are
not rejected by the logic-circuitry which analyses
Signals in respect to artifacts. The Hewlett-Packard
cardiograph 8030A does not allow a deviation in
excess of ± 28 bpm. Frequent unidirectional pen
excursions with a constant amplitude are character-
istic for arrhythmiäs and the Signals in the oscillo-
scope can be diagnostically analyzed. Irregulär
pen excursions with frequent pen-lift on the other
hand are typical for artifacts.
The incidence of persistent fetal rhythm disturb-
ances is less than 1% [1,2]. Eaflier investigations
[1] found in 39.5% of prenatal ECGs a Variation in
rhythm of more thän 20 beats per minute. Dis-
turbances of normal rates are fetal paroxysmal
tachyarrhythmias äs well äs fetal extrasystole or
complete or incomplete AV block.
Prenatally recorded fetal arrhythmiäs are not
found after birth in 85% of the newborns. Persis-
tent rhythm anomalies are associated with cardiac
defects in less than 3% of cases [1,2]. The clinical
importance of the diagnosis of fetal rhythm ano-
malies is emphasized by the fetal paroxysmal
tachycardia described above. WOOD [10] has
shown that a persistent paroxysmal tachycardia
may lead to a myocardial insufficiency. Therefore,
signs of cardiac decompensation such äs the sono-
graphic documentation of ascites in the fetal
abdomen should be looked1 for. Paroxysmal tachy-
cardias are almost exclusively of supraventricular
origin. The treatment consists of the use of Vera-
pamil in combination with digitalis to the mother
[6, 7, 8]. This treatment brings about a normaliza-
tion of the heart rate by inhibiting AV conduction
and Prolongation of the refactory time [7].





























* Oral administration of 80 mg Verapamil.
n.d.: no determinable concentration of Verapamil. Lower limit of detection 4 ng/ml plasma.
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VALERIUS [11] in 1978 was the first to report
a successful treatment of fetal supraventricular
tachycardia by maternal digitalization. In our
case we treated with 0-acetyldigoxin and Vera-
pamil in the dosages mentioned and fetal heart
rate because normal during treatment.
The basis for the treatment were studies on the
placental transfer of the two drugs used. ROGERS
[5] demonstrated that digoxin concentrations in
the umbilical biood was the same äs that in the
maternal blood in women who received longterm
digitalis treatment because of heart disease. There-
fore, a free transfer of digoxin must be assumed.
The placental transfer of Verpamil in humans has
not been investigated before. We were able to de-
monstrate placental transfer after a one time dose
of 80 mg of Verapamil during delivery.
This confirmed animal experiments by STRIGL
[9]. Concentration in the fetus after one time oral
administration to the mother were 15.4 ng/ml
after 49 minutes and 24.5 ng/ml plasma after 109
minutes. Thus, the concentrations in the infant are
markedly less than in the matemal plasma. With
larger time intervals between administration and
delivery no Verapamil was detected in the cord
blood. The question remains open whether phar-
macologically effective drug levels were achieved
in the fetus while administering 240 mg of Vera-
pamil per day.
Summary
This study discusses the diagnosis and therapeutic possib-
ilities of fetal heart rate anomalies in light of three case
reports. A complete AV block which persisted after birth
converted to normal rhythm without treatment. In the
second case extrasystoles in the fetus were not present in
the newborn. The third case of heart rate anomaly was a
paroxysmal tachy-arrhythmia with a rate of 264-282 per
minute which was observed for ten days. In all cases the
diagnosis was made with a prenatal fetal ECG. The first
two disturbances were also recorded with the cardioto-
gram. The fetal extrasystole was manifest in the cardio-
tocogram by unidirectional excusions of the pen with
constant amplitude and simultaneous extrasystoles on the
oscilloscope. In the third case of a fetal paroxysmal tachy-
cardia the cardiotocograph did not record the arrhythmia
because the rate exceeded the ränge of the cardiotoco-
graph. Because of a fetal caidiac insufficiency the mother
was treated with 0-acetyldigoxin and Verapamil. During
this therapy the fetal heart rate became normal until
delivery. We investigated the placental transfer of Vera-
pamil because it had not been investigated previously in
humans. The concentration in the umbilical venous blood
49 and 109 minutes after administration of 80 mg Vera-
pamil to the mother was 15.4 and 24.5 ng/mlrespectively;
these levels were less than those in the maternal plasma.
At longer intervals between administration and delivery
the Verapamil levels in the umbilical venous blood was
below a detectable level. Therefore, it has been shown
that Verapamil passes through the placenta.
Keywords: Fetal electrocardiogram, fetal heart rate anomalies, pharmacokinetics of Verapamil.
Zusammenfassung
Pränatale Diagnostik und Therapie fetaler Herzfrequenz-
anomalien. Mit einem Beitrag zui Plazentagängigkeit von
In der vorliegenden Arbeit wird über die Diagnostik und
therapeutische Möglichkeiten bei fetalen Herzfrequenz-
anomalien anhand von 3 kasuistischen Beispielen berich-
tet. Ein kompletter AV-Block, der zunächst postpartal
fortbestand, normalisierte sich ohne Therapie. Im zweiten
Fall einer fetalen Extrasystolie konnte diese Frequenz-
anomalie beim Neugeborenen nicht mehr nachgewiesen
werden. Bei der dritten Herzfrequenzveränderung han-
delte es sich um eine über 10 Tage beobaclitete paroxys-
male Tachyarrhythmie mit einer Frequenz von 264-2S2/
Minute. In allen Fällen erfolgte die Diagnostik durch das
pränatale fetale EKG. Bei den beiden erstgenannten Stö-
rungen gelang die Registrierung auch bei der Kardio-
tokografieaufzeichnung, wobei die fetale Extrasystolie
bei der subpartualen direkten EKG-Ableitung mit der
Scalp-Elektrode durch gleichgerichtete Schreiberaus-
schläge mit konstanter Amplitude und gleichzeitigem os-
zilloskopischem Nachweis der Extrasystolen gesichert
wurde. Im dritten Fall einer fetalen paroxysmalen Tachy-
arrhythmie gelang keine kardiotokografische Registrie-
rung, da die Frequenz der Signale den vorgegebenen
Bereich überschritten. Wegen einer fetalen Herzinsuf-
fizienz wurde eine Behandlung der Mutter mit 0-Acetyl-
digoxin und Verapamil durchgeführt. Unter dieser Thera-
pie gelang eine Normalisierung der fetalen Herzfrequenz
bis zur Geburt. Da über die Plazentapassage von Verapa-
mil beim Menschen im Gegensatz zu Digoxin, bei dem
ein freier Übertritt bekannt ist, keine Mitteilungen vor-
liegen, untersuchten wir die Plazentagängigkeit dieser
Substanz. Die Plasmakonzentrationen betrugen nach
einmaliger oraler Einnahme von 80 mg Verapamil durch
die Schwangere unter der Geburt im Nabelvenenblut nach
49 und 109 Minuten 15,4 und 24,5 ng/ml und lagen
J. Perinat. Med. 8(1980)
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damit unterhalb der Konzentrationen im mütterlichen
Plasma. Bei größeren Zeitintervallen zwischen Einnahme
und Geburt lagen die Verapamilkonzentrationen im Na-
belschnurplasma unterhalb der Nachweisgrenze. Die Pla-
zentagängigkeit dieser Substanz ließ sich daher auch für
den Menschen sichern. .· r
Schlüsselwörter: Fetales Elektrokardiogramm, fetale Herzfrequenzanomalien, Pharmakokinetik von Verapamil.
Resume
Diagnostic et traitement prenataux des anomalies de la
frequence cardiaque foetale
II est fait etat, dans le present travail du diagnostic et des
possibilites therapeutiques fa$e a des anomales de la fre-
quence cardiaque foetale, et ceci a Faide de trois exemples
casuistiques. Un bloc auriculo-verticulaire complet, qui a
persiste au debut de la periode postnatale, a regresse
spontanement. Dans le deuxieme cas une extrasystolie
foetale n'a plus pu etre retrouvee apres la naissance. Dans
le troisieme cas il s'agissait d'une tachyarrhythmie paro-
xystique d'une frequence se situant entre 264 et 282 bat-
tements par minute et qui a ete observee pendant plus de
10 jours. Le diagnostic a ete observee pendant plus de 10
jours. Le diagnostic a ete pose dans tous les cas au moyen
de FECG foetal prenatal. Dans les deux premiers cas
'· Fanomalie a pu egalement etre enregistree a la cardiotoco-
graphie; l'extrasystolie foetale a ete prouvee lors de la
derivation prepartale directe d'ECG a Telectrode au scalp
a l'aide de signaux d'enregistrement de meme sens, d'am-
plitude constante et de preuve oscilloscopique simultanee
d'extrasystoles. Dans le troisieme cas, celui de la tachyar-
rhythmie foetale paroxystique, l'enregistrement cardio-
tocographique n'a pu etre realise du fait du depassement
de l'intervalle d'enregistrement par la frequence des
signaux. II a ete entrepris un traitement maternel par la
0-acetyldigoxine et le verapamil dont la visee etait une in-
suffisance cardiaque foetale. Sous cette therapeutique la
frequence cardiaque foetale s'est normalisee jusqu'a
l'accouchement. Nous avons analyse la permeabilite pla-
centaire pour le verapamil pour lequäl, a l'inverse de la
digoxine, il n'y a pas de donnees dans la litterature. Les
cöncentrations plasmatiques dans les veines ombilicales
etaient de 15.4 et de 24,5 Mg/ml 49 ou 109 minites apres
l'administration orale unique a la parturiente de 80 mg
de verapamil, et ainsi etaient-elles au dessous de celle du
plasma maternel. Lorsque les intervalles de temps entre
prise medicamenteuse et accouchement etaient superi-
eurs, les cöncentrations veineuses funiculaires de vera-
pamil etaient aü dessous du seuil dosable. Ainsi la perme-
abilite placentaire pour cette substance pour Fespece
humaines s'en est-elle trouvee ainsi prouvee.
Mots-cles: Anomalies de frequence cardiaque foetale, electrocardiogramme foetal, pharmacocinesie du verapamil.
Acknowledgement: This work is dedicated to Professor R. KAISER on his 60th birthday.
Bibliography
[1]BOLTE, A.: Die pränatale fetale Elektrokardio-
graphie. Gynäkologie 2 (1969) 63
[2] BOLTE, A., R. BERENDES: Frequenz und Rhyth-
mus der fetalen Herzaktionspotentiale im Verlauf
der Gravidität. Geburtsh. u. Frauenheilk. 32 (1972)
635
[3] FISCHER, W. M.: Kardiotokographie. Thieme
[4] HEGE, H. G.: Gaschromatographic determination
of Verapamil in plasma and urine. Arzneimittel-
forsch./Drug Res. 29 (1979) 1681
[5] ROGERS, M. C., J. F. WlLLERSON, A. GOLD-
BLATT, W. SMITH: Serumdigoxin cöncentrations
in human fetus, neonate and infant. N. Eng. J. Med.
287(1972) 1010
[6] SCHOMERUS, B., B. SIEGELHALDER, B. STIE-
REN, M. EICHELBAUM: Physiological disposition
of Verapamil in man. Cardiovas. Res. 10 (1976) l
[7] SINGH, B. N., G. ELLROTH, C. T. PETER: Vera-
pamil: A review of its pharmacological properties
and therapeutic use. Drugs 15 (1978) 169
[8] SPIEGELHALDER, B., M. EICHELBAUM: Determi-
nation of Verapamil in human plasma by mass-
fragmentography using stable* isotope-labelled Vera-
pamil äs internal Standard. Arzn.mittelforsch. 27
(1977) 94
[9JSTRIGL, R., W. ERHARDT, H. G. HEGE, G.
BÜMEL: Untersuchungen zur Plazentapassage von
Verapamil beim Meerschweinchen. Z. Geburtsh.
Perinat. 183 (1979) 109
[10] WOOD, P.: Polyuria in paroxysmal tachycaidia and
paroxysmal artrial flutter. Brit. Herat J. 25 (1963)
273
[11] VALERIUS, N. H., J. R. JACOBSEN: Intrauterine
supraventricular tachycardia. Acta Obstet. Gynecol.
Scand.57(1978)407
Received November 22, 1979. Revised January 28,1980.





J. Perinat. Med. 8 (1980)
